Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine

S Khanra, P Reddy, A Giménez-Palomo… - Molecular …, 2023 - nature.com
Bipolar disorder's core feature is the pathological disturbances in mood, often accompanied
by disrupted thinking and behavior. Its complex and heterogeneous etiology implies that a …

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

GS Malhi, E Bell, D Bassett, P Boyce… - Australian & New …, 2021 - journals.sagepub.com
Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …

Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo …

F Bartoli, D Cavaleri, B Bachi, F Moretti, I Riboldi… - Journal of Psychiatric …, 2021 - Elsevier
Several drugs previously tested in clinical trials and approved for different indications have
been repurposed for bipolar disorder. We carried out a systematic meta-review of meta …

The emerging role of psilocybin and MDMA in the treatment of mental illness

H Gill, B Gill, D Chen-Li, S El-Halabi… - Expert Review of …, 2020 - Taylor & Francis
Introduction Mental illness has a chronic course of illness with a number of clinical
manifestations. Affected individuals experience significant functional, emotional, cognitive …

[HTML][HTML] Cognitive attentional syndrome and metacognitive beliefs as potential treatment targets for metacognitive therapy in bipolar disorder

S Batmaz, AE Altinoz, HO Sonkurt - World journal of psychiatry, 2021 - ncbi.nlm.nih.gov
Most treatment guidelines emphasize the use of psychotropic drugs for both the acute and
maintenance treatment of bipolar disorder (BD). However, relying only on psychotropics …

Menopause in women with schizophrenia, schizoaffective disorder and bipolar disorder

A Szeliga, B Stefanowski, B Meczekalski, M Snopek… - Maturitas, 2021 - Elsevier
The transition to menopause, usually occurring between the ages of 40 and 55, is a time
when women are particularly vulnerable. When preexisting mental illness is present …

Potential mechanisms of action of resveratrol in prevention and therapy for mental disorders

S Menegas, GS Keller, T Possamai-Della… - The Journal of …, 2023 - Elsevier
There is a growing body of evidence about the potential of diet and nutrients to improve the
population's mental health and the treatment of psychiatric disorders. Some studies have …

Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review

L Cai, G Chen, H Yang, Y Bai - International Clinical …, 2023 - journals.lww.com
The whole picture of psychotropics for bipolar depression (BPD) remains unclear. This
review compares the differences in efficacy and safety profiles among common …

Sleep, mood disorders, and the ketogenic diet: potential therapeutic targets for bipolar disorder and schizophrenia

J Choi, J Kang, T Kim, CJ Nehs - Frontiers in Psychiatry, 2024 - frontiersin.org
Bipolar disorder and schizophrenia are serious psychiatric conditions that cause a
significant reduction in quality of life and shortened life expectancy. Treatments including …

Management Strategies for Borderline Personality Disorder and Bipolar Disorder Comorbidities in Adults with ADHD: A Narrative Review

L MacDonald, J Sadek - Brain Sciences, 2023 - mdpi.com
This narrative review examines two of the common comorbidities of attention-
deficit/hyperactivity disorder, bipolar disorder (BD), and borderline personality disorder …